Skip to main content
Caplight Logo









Xiaoyaoyao

Xiaoyaoyao

Private
WuhanHealthcare & Life Scienceshttps://www.ybm100.com/new/login

Last Round

Series D

Feb 1, 2021

Est. Valuation

$75.5M

Total Funding Raised

$25.18M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Xiaoyaoyao is a healthtech company that operates a B2B pharmaceutical e-commerce platform connecting pharmacies and clinics with drug manufacturers.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Vertical SaaS, Supply Chain

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS

AI Layer

Application

Keywords

pharmaceutical supply chainB2B marketplacepharma e-commercevertical SaaSpharmacy procurementinventory managementdigital healthsupply chain managementSaaShealthtechpharma techB2B e-commercedata analyticsAI-augmented

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xiaoyaoyao Comparables

Compare Xiaoyaoyao with similar companies based on industry and business-model similarity.

Xiaoyaoyao comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
111, Inc.
84%
Pharmacist Bang
80%
Jointown Pharmaceutical Group
65%

Xiaoyaoyao Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DFeb 1, 2021
Series COct 16, 2018
Series BNov 12, 2017
Series AJan 1, 2017
AngelDec 1, 2015

Xiaoyaoyao Investors

Notable investors and investment history

Xiaoyaoyao investors
InvestorRounds
清科资本Series B, Series A, Series C
Sequoia CapitalSeries D
Ameba CapitalSeries B, Angel
Source Code CapitalSeries D, Series C, Series B
SDIC Taikang TrustSeries D
HongShan Capital Group (HSG)Series C
Haier CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 32% MoM.

  • Feb 1, 2021

    SDIC Taikang Trust led the round with participation from Sequoia Capital and Tencent.

Xiaoyaoyao Filings

Explore SEC and related filing metadata, where available.

Xiaoyaoyao filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xiaoyaoyao's valuation, stock price, and market status.

Is Xiaoyaoyao a public or private company?

Xiaoyaoyao is a private company.

What is the current stock price of Xiaoyaoyao?

Xiaoyaoyao is a private company with no public stock price. No recent secondary market data is available.

How much is Xiaoyaoyao worth (valuation)?

Xiaoyaoyao's valuation is estimated at $75.5M based on funding round data.

Can I buy Xiaoyaoyao stock?

Xiaoyaoyao shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xiaoyaoyao's last funding round?

Xiaoyaoyao's most recent funding round was Series D on November 11, 2017.

Who are the main investors in Xiaoyaoyao?

Key investors in Xiaoyaoyao include Source Code Capital, SDIC Taikang Trust.

Will Xiaoyaoyao IPO soon?

No public IPO plans have been announced for Xiaoyaoyao.

How can I track Xiaoyaoyao secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xiaoyaoyao's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWuhan
Employee Range16
Year Founded2016
Last FundingFeb 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?